Brazil authorises trials with 3rd dose of AstraZeneca COVID vaccine

Brazil's health regulator Anvisa said on Monday that it has approved trials with a third dose of the AstraZeneca vaccine against COVID-19.

>>Reuters
Published : 19 July 2021, 02:49 PM
Updated : 19 July 2021, 03:24 PM

Anvisa said a third dose of the vaccine would be administered to 10,000 volunteers between 11 and 13 months after the second shot.